The Smartest Growth Stocks to Buy With $2,000 Right Now Most of the market's best-known growth names are overbought at this time. That's not the case for several off-the-radar alternatives.
Stock Market Today, May 28: Tech Stocks Rise as Snowflake Surges After $6 Billion Amazon Deal and Strong Earnings Today, May 28, 2026, investors piled into Snowflake after its Amazon pact and earnings beat, even as the Dow barely budged.
Why Eli Lilly (LLY) Stock Is Trading Up Today What Happened? Shares of global pharmaceutical company Eli Lilly (
NYSE:LLY ) jumped 3.4% in the afternoon session after CVS restored Zepbound as a co-preferre...
Contrarian Opinion: Novo Nordisk Is A Better Buy Than Eli Lilly Right Now Novo Nordisk lost its lead in the GLP-1 race, but Eli Lilly's valuation is a bit rich.
Why Is Eli Lilly Stock Surging On Thursday? Eli Lilly (
NYSE:LLY ) shares jumped on Thursday morning after securing expanded PBM coverage for its blockbuster obesity treatments, Zepbound and Foundayo.
Hims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders? Hims & Hers is acquiring Australian telehealth platform Eucalyptus as part of its international expansion plan while using $350 million in convertible senior notes.
VHT vs. XBI: Vanguard Health Care ETF Tops SPDR Biotech in Yield and Cost Expense ratios, yield, and sector breadth set these healthcare ETFs apart—see how their risk profiles and portfolio strategies compare.
Is Eli Lilly Stock Outperforming the Nasdaq? Eli Lilly has outpaced the Nasdaq Composite over the past year, and analysts remain very confident in its longer-term trajectory.
Is Johnson & Johnson Stock Outperforming the Dow? Johnson & Johnson has outperformed the Dow Jones over the past year, and analysts remain moderately optimistic about the stock’s outlook.
5 Undervalued Stocks You Can Buy and Hold Forever Buying and holding stocks is an excellent strategy to increase your wealth.
3 Healthcare Stocks We Keep Off Our Radar Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recentl...
2 Mega-Cap Stocks on Our Buy List and 1 We Find Risky Megacap stocks dominate their sectors and their actions influence economies worldwide. The flip side though is that their sheer size means they have less roo...
The $4 Billion Reason Eli Lilly Stock Is Up Today Eli Lilly shares inch higher as the company announced three acquisitions for nearly $4 billion. Here’s why each of the three vaccine makers it’s buying is bullish for LLY stock.
GLP-1 Drugs Powered IHE's Big Year. IXJ Is Playing a Longer Game. A closer look at portfolio makeup, yield, and risk reveals what sets these two iShares healthcare funds apart for investors seeking sector exposure.
PPH vs. IXJ: A Pure Pharma Bet Against the Entire Global Healthcare Ecosystem A concentrated pharma focus sets VanEck apart from iShares’ broader healthcare approach. See how portfolio differences shape risk and income profiles.
Micron Just Became America's 10th-Most-Valuable Company. Wall Street Says It Could Pass Tesla and Meta Next. Surging demand for the memory chipmaker's AI products has sent its stock soaring. But a rally this steep doesn't come without risk.
Is Eli Lilly Stock an Undervalued Stock to Buy? Consumer demand for Eli Lilly's weight-loss treatments continues to rise.
Investment Firm Closes Out Entire $18.1 Million Position in Biotech Stock, According to Latest SEC Filing This biotech focuses on biologic therapies for immunological diseases, with lead candidates in nephrology and infectious disease.
From Shingles To Superbugs: Eli Lilly Expands Infectious Disease Push In Billion-Dollar Buying Wave Eli Lilly acquires Curevo, LimmaTech, and Vaccine Co. to expand its infectious disease portfolio and advance long-term disease prevention.
